Probiotic therapy - recruiting old friends to fight new foes (Q42652018)

4 November 2017

0 references

Probiotic therapy - recruiting old friends to fight new foes (English)

1 reference

4 November 2017

0 references

1

Roy D Sleator

1 reference

4 November 2017

25 June 2010

1 reference

4 November 2017

1 reference

4 November 2017

2

1 reference

4 November 2017

1

1 reference

4 November 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1186/1757-4749-2-5

4 November 2017

0 references

cites work

The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912230

Health-beneficial effects of probiotics: Its mode of action

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912230

Probiotics: multifarious oral vaccine against infectious traumas

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912230

Probiotics and gastrointestinal disease: successes, problems and future prospects

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912230

Rational design of improved pharmabiotics

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912230

The interaction between Listeria monocytogenes and the host gastrointestinal tract.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912230

Lantibiotics: diverse activities and unique modes of action

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912230

Probiotics, prebiotics and competitive exclusion for prophylaxis against bacterial disease

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912230

Antimicrobial peptides and bacteriocins: alternatives to traditional antibiotics

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912230

Enhancing bile tolerance improves survival and persistence of Bifidobacterium and Lactococcus in the murine gastrointestinal tract

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912230

New frontiers in probiotic research

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912230

Activity of HIV entry and fusion inhibitors expressed by the human vaginal colonizing probiotic Lactobacillus reuteri RC-14.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912230

From cheese to pharma: a designer probiotic for IBD

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912230

Patho-biotechnology: using bad bugs to do good things

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912230

Alternatives to antibiotics: bacteriocins, antimicrobial peptides and bacteriophages

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912230

Probiotics: determinants of survival and growth in the gut.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912230

Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912230

'Bioengineered Bugs' - a patho-biotechnology approach to probiotic research and applications.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912230

16 August 2018

1 reference

12 December 2020

Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003

1 reference

PubMed

12 December 2020

Designer probiotics: a potential therapeutic for Clostridium difficile?

1 reference

PubMed

12 December 2020

Receptor-mimic probiotics: potential therapeutics for bacterial toxin-mediated enteric diseases

1 reference

PubMed

12 December 2020

Identifiers

DOI

10.1186/1757-4749-2-5

1 reference

PMC publication ID

2912230

Dimensions Publication ID

4 November 2017

0 references

1 reference

PMC publication ID

2912230

4 November 2017

PubMed publication ID

20579345

1 reference

PMC publication ID

2912230